rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Donald P. Braun

Director

Company insider

Files Form 4 as: Director, Imunon.

In numbers

Trades disclosed
29
Buys
2
Sells
0
Bought
$35K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
15 Dec 2015
Last trade
31 Jul 2026
Last filed
4 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
IMNN ImunonDirector · Biotechnology · last 31 Jul 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
101Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$9,8266,180 at $1.59filing
31 Jul 2026filed 4 Aug 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$9,8266,180 at $1.59filing
22 May 2026filed 27 May 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$11K5,011 at $2.20filing
22 May 2026filed 27 May 2026IMNN ImunonBiotechnologySEC FORM 4 Code A$11K5,011 at $2.20filing
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—5,881 at $0.00filing
2 Jan 2026filed 6 Jan 2026IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—5,881 at $0.00filing
4 Aug 2025filed 6 Aug 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—250 at $0.00filing
4 Aug 2025filed 6 Aug 2025IMNN ImunonBiotechnologySEC FORM 4 Code A$19K2,040 at $9.20filing
14 Mar 2025filed 18 Mar 2025IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,750 at $0.00filing
6 Sep 2024filed 10 Sep 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—9,072 at $0.00filing
20 Aug 2024filed 28 Jan 2025IMNN ImunonBiotechnologySEC FORM 4 Bought$30K25,000 at $1.18filing
12 Jun 2024filed 14 Jun 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,500 at $0.00filing
15 Mar 2024filed 18 Mar 2024IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—3,500 at $0.00filing
17 Mar 2023filed 21 Mar 2023IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—2,000 at $0.00filing
13 Jun 2022filed 15 Jun 2022IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—6,250 at $0.00filing
4 Mar 2022filed 7 Mar 2022IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—6,250 at $0.00filing
17 May 2021filed 20 May 2021IMNN ImunonBiotechnologySEC FORM 4 Bought$5,3505,000 at $1.07filing
19 Mar 2021filed 22 Mar 2021IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—40,000 at $0.00filing
15 Jun 2020filed 16 Jun 2020IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code A—4,000 at $0.00filing
15 Jun 2020filed 16 Jun 2020IMNN Imunonoption or derivative · BiotechnologySEC FORM 4 Code D—50,000 at $0.00filing

News

IMUNON To Sell ThermoDox Rights To VoxelDox For Glioblastoma MultiformeIMNN · rttnews.com · 21 Oct 2026

0 headlines in the last 90 days name Donald P. Braun; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Douglas Vincent FallerChief Medical Officer · Chief Medical Officer at Imunon, filing Form 4 there in the last year
Stacy LindborgPresident and CEO · President and CEO at Imunon, filing Form 4 there in the last year
Michael H. TardugnoExecutive Chairman of Board · Executive Chairman of Board at Imunon, filing Form 4 there in the last year
Susan EylwardGeneral Counsel and Corp Sec · General Counsel and Corp Sec at Imunon, filing Form 4 there in the last year
Christine A. PellizzariDirector · Director at Imunon, filing Form 4 there in the last year